{"id":1725,"date":"2019-09-17T14:57:34","date_gmt":"2019-09-17T14:57:34","guid":{"rendered":"https:\/\/vetmed.illinois.edu\/freemantle-lab\/?page_id=1725"},"modified":"2025-08-15T12:45:31","modified_gmt":"2025-08-15T17:45:31","slug":"spinella-publications","status":"publish","type":"page","link":"https:\/\/vetmed.illinois.edu\/spinella-freemantle-lab\/spinella-publications\/","title":{"rendered":"Spinella Publications"},"content":{"rendered":"

SPINELLA PUBLICATIONS<\/h2>\n<\/div>
<\/div>
<\/div><\/div>
<\/div>
<\/div><\/div><\/div>
\n
\n
<\/div>\n<\/div>\n<\/article>\n
\n
\n
\n
<\/div>\n<\/div>\n<\/div>\n<\/article>\n
    \n
  1. Park CJ, Oh JE, Lin P, Zhou S, Bunnell M, Bikorimana E, Spinella MJ, Lim HJ, Ko CJ. A Dynamic Shift in Estrogen Receptor Expression During Granulosa Cell Differentiation in the Ovary. Endocrinology. 2025 Jan 6;166(2):bqaf006<\/li>\n
  2. Shokry D, Khan MW, Powell C, Johnson S, Rennels BC, Boyd RI, Sun Z, Fazal Z, Freemantle SJ, Parker MH, Vieson MD, Samuelson JP, Spinella MJ, Singh R. Refractory testicular germ cell tumors are highly sensitive to the targeting of polycomb pathway demethylases KDM6A and KDM6B. Cell Commun Signal. 2024 Oct 31;22(1):528.<\/li>\n
  3. Boyd RI, Shokry D, Fazal Z, Rennels BC, Freemantle SJ, La Frano MR, Prins GS, Madak Erdogan Z, Irudayaraj J, Singh R, Spinella MJ. Perfluorooctanesulfonic Acid Alters Pro-Cancer Phenotypes and Metabolic and Transcriptional Signatures in Testicular Germ Cell Tumors. Toxics. 2024 Mar 22;12(4):232.<\/li>\n
  4. Corbet AK, Bikorimana E, Boyd RI, Shokry D, Kries K, Gupta A, Paton A, Sun Z, Fazal Z, Freemantle SJ, Nelson ER, Spinella MJ, Singh R. G0S2 promotes antiestrogenic and pro-migratory responses in ER+ and ER- breast cancer cells. Transl Oncol. 2023 Jul;33:101676.<\/li>\n
  5. Zhang X, Flaws JA, Spinella MJ, Irudayaraj J. The Relationship between Typical Environmental Endocrine Disruptors and Kidney Disease. Toxics. 2022 Dec 29;11(1):32.<\/li>\n
  6. Nelczyk AT, Ma L, Gupta AD, Gamage HEV, McHenry MT, Henn MA, Kadiri M, Wang Y, Krawczynska N, Bendre S, He S, Shahoei SH, Madak-Erdogan Z, Hsiao SH, Saleh T, Carpenter V, Gewirtz DA, Spinella MJ,<\/b> Nelson ER. The nuclear receptor TLX (NR2E1) inhibits growth and progression of triple- negative breast cancer. Biochim Biophys Acta Mol Basis Dis. 2022 Aug 4;1868(11):166515. doi: 10.1016\/j.bbadis.2022.166515. Epub ahead of print. PMID: 35932893.<\/li>\n
  7. Boyd RI, Ahmad S, Singh R, Fazal Z, Prins GS, Madak Erdogan Z, Irudayaraj J, Spinella MJ. <\/b>Toward a Mechanistic Understanding of Poly- and Perfluoroalkylated Substances and Cancer. Cancers (Basel). 2022 Jun 14;14(12):2919. doi: 10.3390\/cancers14122919. PMID: 35740585; PMCID: PMC9220899.<\/li>\n
  8. Wen Y, Rashid F, Fazal Z, Singh R, Spinella MJ<\/b>, Irudayaraj J. Nephrotoxicity of perfluorooctane sulfonate (PFOS)-effect on transcription and epigenetic factors. Environ Epigenet. 2022 Apr 16;8(1):dvac010. doi: 10.1093\/eep\/dvac010. PMID: 35633893; PMCID: PMC9134076.<\/li>\n
  9. Imir OB, Kaminsky AZ, Zuo QY, Liu YJ, Singh R, Spinella MJ,<\/b> Irudayaraj J, Hu WY, Prins GS, Madak Erdogan Z. Per- and Polyfluoroalkyl Substance Exposure Combined with High-Fat Diet Supports Prostate Cancer Progression. Nutrients. 2021 Oct 30;13(11):3902. doi: 10.3390\/nu13113902. PMID: 34836157; PMCID: PMC8623692.<\/li>\n
  10. Singh R, Fazal Z, Bikorimana E, Boyd RI, Yerby C, Tomlin M, Baldwin H, Shokry D, Corbet AK, Shahid K, Hattab A, Freemantle SJ, Spinella MJ<\/b>. Reciprocal epigenetic remodeling controls testicular cancer hypersensitivity to hypomethylating agents and chemotherapy. Mol Oncol. 2022 Feb;16(3):683-698. doi: 10.1002\/1878-0261.13096. Epub 2021 Sep 15. PMID: 34482638; PMCID: PMC8807365.<\/li>\n
  11. Between a Rock and a Hard Place: An Epigenetic-Centric View of Testicular Germ Cell Tumors.<\/a>\n
    Singh R, Fazal Z, Freemantle SJ, Spinella MJ.<\/b><\/span>Cancers (Basel). 2021 Mar 25;13(7):1506. doi: 10.3390\/cancers13071506.<\/span><\/div>\n<\/li>\n
  12. A phase 1 study of combined guadecitabine and cisplatin in platinum refractory germ cell cancer.<\/a>\n
    Albany C, Fazal Z, Singh R, Bikorimana E, Adra N, Hanna NH, Einhorn LH, Perkins SM, Sandusky GE, Christensen BC, Keer H, Fang F, Nephew KP, Spinella MJ.<\/b><\/span>Cancer Med. 2021 Jan;10(1):156-163. doi: 10.1002\/cam4.3583. Epub 2020 Nov 1.<\/span><\/div>\n<\/li>\n
  13. \n
    \n

    Hypermethylation and global remodelling of DNA methylation is associated with acquired cisplatin resistance in testicular germ cell tumours.<\/a>Fazal Z, Singh R, Fang F, Bikorimana E, Baldwin H, Corbet A, Tomlin M, Yerby C, Adra N, Albany C, Lee S, Freemantle SJ, Nephew KP, Christensen BC, Spinella MJ.<\/b><\/span>Epigenetics. 2020 Oct 30:1-14. doi: 10.1080\/15592294.2020.1834926. Online ahead of print.<\/span>PMID: 33126827<\/span><\/span><\/p>\n<\/div>\n<\/li>\n

  14. Mechanisms of cisplatin sensitivity and resistance in testicular germ cell tumors.<\/a>
    \nSingh R, Fazal Z, Freemantle SJ, Spinella MJ.<\/strong>
    \nCancer Drug Resist<\/span>. 2019;2(3):580-594. doi: 10.20517\/cdr.2019.19. Epub 2019 Sep 19.<\/li>\n
  15. The potential of retinoids for combination therapy of lung cancer: Updates and future directions.<\/a>
    \nTripathi SK, Pandey K, Panda M, Spinella MJ, Rengasamy KR, Biswal BK.
    \nPharmacol Res<\/span>. 2019 Sep;147:104331. doi: 10.1016\/j.phrs.2019.104331. Epub 2019 Jun 26. Review.
    \nPMID: 31254665 [PubMed – in process]\n    Similar articles<\/a><\/li>\n
  16. Epigenetic Remodeling through Downregulation of Polycomb Repressive Complex 2 Mediates Chemotherapy Resistance in Testicular Germ Cell Tumors.<\/a>
    \nSingh R, Fazal Z, Corbet AK, Bikorimana E, Rodriguez JC, Khan EM, Shahid K, Freemantle SJ, Spinella MJ.
    \nCancers (Basel)<\/span>. 2019 Jun 8;11(6). pii: E796. doi: 10.3390\/cancers11060796.
    \nPMID: 31181810 [PubMed] Free PMC Article
    \n    Similar articles<\/a><\/li>\n
  17. Incorporating DNA Methyltransferase Inhibitors (DNMTis) in the Treatment of Genitourinary Malignancies: A Systematic Review.<\/a>
    \nChovanec M, Taza F, Kalra M, Hahn N, Nephew KP, Spinella MJ, Albany C.
    \nTarget Oncol<\/span>. 2018 Feb;13(1):49-60. doi: 10.1007\/s11523-017-0546-x.
    \nPMID: 29230671 [PubMed – indexed for MEDLINE] Free PMC Article
    \n    Similar articles<\/a><\/li>\n
  18. G0S2 represses PI3K\/mTOR signaling and increases sensitivity to PI3K\/mTOR pathway inhibitors in breast cancer.<\/a>
    \nYim CY, Bikorimana E, Khan E, Warzecha JM, Shin L, Rodriguez J, Dmitrovsky E, Freemantle SJ, Spinella MJ.
    \nCell Cycle<\/span>. 2017;16(21):2146-2155. doi: 10.1080\/15384101.2017.1371884. Epub 2017 Sep 14.
    \nPMID: 28910567 [PubMed – indexed for MEDLINE] Free PMC Article
    \n    Similar articles<\/a><\/li>\n
  19. Refractory testicular germ cell tumors are highly sensitive to the second generation DNA methylation inhibitor guadecitabine.<\/a>
    \nAlbany C, Hever-Jardine MP, von Herrmann KM, Yim CY, Tam J, Warzecha JM, Shin L, Bock SE, Curran BS, Chaudhry AS, Kim F, Sandusky GE, Taverna P, Freemantle SJ, Christensen BC, Einhorn LH, Spinella MJ.
    \nOncotarget<\/span>. 2017 Jan 10;8(2):2949-2959. doi: 10.18632\/oncotarget.13811.
    \nPMID: 27936464 [PubMed – indexed for MEDLINE] Free PMC Article
    \n    Similar articles<\/a><\/li>\n
  20. Epigenetic Targeting of Platinum Resistant Testicular Cancer.<\/a>
    \nSonnenburg D, Spinella MJ, Albany C.
    \nCurr Cancer Drug Targets<\/span>. 2016;16(9):789-795. Review.
    \nPMID: 26694252 [PubMed – indexed for MEDLINE] Free PMC Article
    \n    Similar articles<\/a><\/li>\n
  21. G0S2 Suppresses Oncogenic Transformation by Repressing a MYC-Regulated Transcriptional Program.<\/a>
    \nYim CY, Sekula DJ, Hever-Jardine MP, Liu X, Warzecha JM, Tam J, Freemantle SJ, Dmitrovsky E, Spinella MJ.
    \nCancer Res<\/span>. 2016 Mar 1;76(5):1204-13. doi: 10.1158\/0008-5472.CAN-15-2265. Epub 2016 Feb 2.
    \nPMID: 26837760 [PubMed – indexed for MEDLINE] Free PMC Article
    \n    Similar articles<\/a><\/li>\n
  22. All-trans-retinoic acid antagonizes the Hedgehog pathway by inducing patched.<\/a>
    \nBusch AM, Galimberti F, Nehls KE, Roengvoraphoj M, Sekula D, Li B, Guo Y, Direnzo J, Fiering SN, Spinella MJ, Robbins DJ, Memoli VA, Freemantle SJ, Dmitrovsky E.
    \nCancer Biol Ther<\/span>. 2014 Apr;15(4):463-72. doi: 10.4161\/cbt.27821. Epub 2014 Feb 4.
    \nPMID: 24496080 [PubMed – indexed for MEDLINE] Free PMC Article
    \n    Similar articles<\/a><\/li>\n
  23. Headway and hurdles in the clinical development of dietary phytochemicals for cancer therapy and prevention: lessons learned from vitamin A derivatives.<\/a>
    \nYim CY, Mao P, Spinella MJ.
    \nAAPS J<\/span>. 2014 Mar;16(2):281-8. doi: 10.1208\/s12248-014-9562-2. Epub 2014 Jan 16. Review.
    \nPMID: 24431081 [PubMed – indexed for MEDLINE] Free PMC Article
    \n    Similar articles<\/a><\/li>\n
  24. Serine\/threonine kinase 17A is a novel candidate for therapeutic targeting in glioblastoma.<\/a>
    \nMao P, Hever-Jardine MP, Rahme GJ, Yang E, Tam J, Kodali A, Biswal B, Fadul CE, Gaur A, Israel MA, Spinella MJ.
    \nPLoS One<\/span>. 2013 Nov 28;8(11):e81803. doi: 10.1371\/journal.pone.0081803. eCollection 2013.
    \nPMID: 24312360 [PubMed – indexed for MEDLINE] Free PMC Article
    \n    Similar articles<\/a><\/li>\n
  25. Acute hypersensitivity of pluripotent testicular cancer-derived embryonal carcinoma to low-dose 5-aza deoxycytidine is associated with global DNA Damage-associated p53 activation, anti-pluripotency and DNA demethylation.<\/a>
    \nBiswal BK, Beyrouthy MJ, Hever-Jardine MP, Armstrong D, Tomlinson CR, Christensen BC, Marsit CJ, Spinella MJ.
    \nPLoS One<\/span>. 2012;7(12):e53003. doi: 10.1371\/journal.pone.0053003. Epub 2012 Dec 27.
    \nPMID: 23300844 [PubMed – indexed for MEDLINE] Free PMC Article
    \n    Similar articles<\/a><\/li>\n
  26. Modulation of clock gene expression by the transcriptional coregulator receptor interacting protein 140 (RIP140).<\/a>
    \nPoliandri AH, Gamsby JJ, Christian M, Spinella MJ, Loros JJ, Dunlap JC, Parker MG.
    \nJ Biol Rhythms<\/span>. 2011 Jun;26(3):187-99. doi: 10.1177\/0748730411401579.
    \nPMID: 21628546 [PubMed – indexed for MEDLINE] Free PMC Article
    \n    Similar articles<\/a><\/li>\n
  27. Serine\/threonine kinase 17A is a novel p53 target gene and modulator of cisplatin toxicity and reactive oxygen species in testicular cancer cells.<\/a>
    \nMao P, Hever MP, Niemaszyk LM, Haghkerdar JM, Yanco EG, Desai D, Beyrouthy MJ, Kerley-Hamilton JS, Freemantle SJ, Spinella MJ.
    \nJ Biol Chem<\/span>. 2011 Jun 3;286(22):19381-91. doi: 10.1074\/jbc.M111.218040. Epub 2011 Apr 13.
    \nPMID: 21489989 [PubMed – indexed for MEDLINE] Free PMC Article
    \n    Similar articles<\/a><\/li>\n
  28. High DNA methyltransferase 3B expression mediates 5-aza-deoxycytidine hypersensitivity in testicular germ cell tumors.<\/a>
    \nBeyrouthy MJ, Garner KM, Hever MP, Freemantle SJ, Eastman A, Dmitrovsky E, Spinella MJ.
    \nCancer Res<\/span>. 2009 Dec 15;69(24):9360-6. doi: 10.1158\/0008-5472.CAN-09-1490.
    \nPMID: 19951990 [PubMed – indexed for MEDLINE] Free PMC Article
    \n    Similar articles<\/a><\/li>\n
  29. Wnt pathway reprogramming during human embryonal carcinoma differentiation and potential for therapeutic targeting.<\/a>
    \nSnow GE, Kasper AC, Busch AM, Schwarz E, Ewings KE, Bee T, Spinella MJ, Dmitrovsky E, Freemantle SJ.
    \nBMC Cancer<\/span>. 2009 Oct 29;9:383. doi: 10.1186\/1471-2407-9-383.
    \nPMID: 19874621 [PubMed – indexed for MEDLINE] Free PMC Article
    \n    Similar articles<\/a><\/li>\n
  30. Retinoic acid mediates long-paced oscillations in retinoid receptor activity: evidence for a potential role for RIP140.<\/a>
    \nHeim KC, Gamsby JJ, Hever MP, Freemantle SJ, Loros JJ, Dunlap JC, Spinella MJ.
    \nPLoS One<\/span>. 2009 Oct 28;4(10):e7639. doi: 10.1371\/journal.pone.0007639.
    \nPMID: 19862326 [PubMed – indexed for MEDLINE] Free PMC Article
    \n    Similar articles<\/a><\/li>\n
  31. Selective repression of retinoic acid target genes by RIP140 during induced tumor cell differentiation of pluripotent human embryonal carcinoma cells.<\/a>
    \nHeim KC, White KA, Deng D, Tomlinson CR, Moore JH, Freemantle SJ, Spinella MJ.
    \nMol Cancer<\/span>. 2007 Sep 19;6:57.
    \nPMID: 17880687 [PubMed – indexed for MEDLINE] Free PMC Article
    \n    Similar articles<\/a><\/li>\n
  32. The direct p53 target gene, FLJ11259\/DRAM, is a member of a novel family of transmembrane proteins.<\/a>
    \nKerley-Hamilton JS, Pike AM, Hutchinson JA, Freemantle SJ, Spinella MJ.
    \nBiochim Biophys Acta<\/span>. 2007 Apr;1769(4):209-19. Epub 2007 Feb 22.
    \nPMID: 17397945 [PubMed – indexed for MEDLINE] Free PMC Article
    \n    Similar articles<\/a><\/li>\n
  33. Nestin is expressed in the basal\/myoepithelial layer of the mammary gland and is a selective marker of basal epithelial breast tumors.<\/a>
    \nLi H, Cherukuri P, Li N, Cowling V, Spinella M, Cole M, Godwin AK, Wells W, DiRenzo J.
    \nCancer Res<\/span>. 2007 Jan 15;67(2):501-10.
    \nPMID: 17234757 [PubMed – indexed for MEDLINE] Free Article
    \n    Similar articles<\/a><\/li>\n
  34. Repression of cyclin D1 as a target for germ cell tumors.<\/a>
    \nFreemantle SJ, Vaseva AV, Ewings KE, Bee T, Krizan KA, Kelley MR, Hattab EM, Memoli VA, Black CC, Spinella MJ, Dmitrovsky E.
    \nInt J Oncol<\/span>. 2007 Feb;30(2):333-40.
    \nPMID: 17203214 [PubMed – indexed for MEDLINE]\n    Similar articles<\/a><\/li>\n
  35. Testicular Germ Cell Tumors: A Paradigm for the Successful Treatment of Solid Tumor Stem Cells.<\/a>
    \nGiuliano CJ, Freemantle SJ, Spinella MJ.
    \nCurr Cancer Ther Rev<\/span>. 2006 Aug 1;2(3):255-270.
    \nPMID: 24482633 [PubMed] Free PMC Article
    \n    Similar articles<\/a><\/li>\n
  36. Retinoic acid represses a cassette of candidate pluripotency chromosome 12p genes during induced loss of human embryonal carcinoma tumorigenicity.<\/a>
    \nGiuliano CJ, Kerley-Hamilton JS, Bee T, Freemantle SJ, Manickaratnam R, Dmitrovsky E, Spinella MJ.
    \nBiochim Biophys Acta<\/span>. 2005 Oct 15;1731(1):48-56. Epub 2005 Sep 1.
    \nPMID: 16168501 [PubMed – indexed for MEDLINE]\n    Similar articles<\/a><\/li>\n
  37. A p53-dominant transcriptional response to cisplatin in testicular germ cell tumor-derived human embryonal carcinoma.<\/a>
    \nKerley-Hamilton JS, Pike AM, Li N, DiRenzo J, Spinella MJ.
    \nOncogene<\/span>. 2005 Sep 8;24(40):6090-100.
    \nPMID: 15940259 [PubMed – indexed for MEDLINE]\n    Similar articles<\/a><\/li>\n
  38. p53 in human embryonal carcinoma: identification of a transferable, transcriptional repression domain in the N-terminal region of p53.<\/a>
    \nCurtin JC, Spinella MJ.
    \nOncogene<\/span>. 2005 Feb 24;24(9):1481-90.
    \nPMID: 15674351 [PubMed – indexed for MEDLINE]\n    Similar articles<\/a><\/li>\n
  39. Limiting effects of RIP140 in estrogen signaling: potential mediation of anti-estrogenic effects of retinoic acid.<\/a>
    \nWhite KA, Yore MM, Deng D, Spinella MJ.
    \nJ Biol Chem<\/span>. 2005 Mar 4;280(9):7829-35. Epub 2005 Jan 4.
    \nPMID: 15632153 [PubMed – indexed for MEDLINE] Free Article
    \n    Similar articles<\/a><\/li>\n
  40. Retinoids in cancer therapy and chemoprevention: promise meets resistance.<\/a>
    \nFreemantle SJ, Spinella MJ, Dmitrovsky E.
    \nOncogene<\/span>. 2003 Oct 20;22(47):7305-15. Review.
    \nPMID: 14576840 [PubMed – indexed for MEDLINE]\n    Similar articles<\/a><\/li>\n
  41. Negative feedback at the level of nuclear receptor coregulation. Self-limitation of retinoid signaling by RIP140.<\/a>
    \nWhite KA, Yore MM, Warburton SL, Vaseva AV, Rieder E, Freemantle SJ, Spinella MJ.
    \nJ Biol Chem<\/span>. 2003 Nov 7;278(45):43889-92. Epub 2003 Sep 22.
    \nPMID: 14506269 [PubMed – indexed for MEDLINE] Free Article
    \n    Similar articles<\/a><\/li>\n
  42. Retinoid target gene activation during induced tumor cell differentiation: human embryonal carcinoma as a model.<\/a>
    \nSpinella MJ, Kerley JS, White KA, Curtin JC.
    \nJ Nutr<\/span>. 2003 Jan;133(1):273S-276S. Review.
    \nPMID: 12514308 [PubMed – indexed for MEDLINE]\n    Similar articles<\/a><\/li>\n
  43. Characterization and tissue-specific expression of human GSK-3-binding proteins FRAT1 and FRAT2.<\/a>
    \nFreemantle SJ, Portland HB, Ewings K, Dmitrovsky F, DiPetrillo K, Spinella MJ, Dmitrovsky E.
    \nGene<\/span>. 2002 May 29;291(1-2):17-27.
    \nPMID: 12095675 [PubMed – indexed for MEDLINE]\n    Similar articles<\/a><\/li>\n
  44. Developmentally-related candidate retinoic acid target genes regulated early during neuronal differentiation of human embryonal carcinoma.<\/a>
    \nFreemantle SJ, Kerley JS, Olsen SL, Gross RH, Spinella MJ.
    \nOncogene<\/span>. 2002 Apr 25;21(18):2880-9.
    \nPMID: 11973648 [PubMed – indexed for MEDLINE] Free Article
    \n    Similar articles<\/a><\/li>\n
  45. Cyclin proteolysis as a retinoid cancer prevention mechanism.<\/a>
    \nDragnev KH, Freemantle SJ, Spinella MJ, Dmitrovsky E.
    \nAnn N Y Acad Sci<\/span>. 2001 Dec;952:13-22. Review.
    \nPMID: 11795432 [PubMed – indexed for MEDLINE]\n    Similar articles<\/a><\/li>\n
  46. Transcriptional activation of the nuclear receptor corepressor RIP140 by retinoic acid: a potential negative-feedback regulatory mechanism.<\/a>
    \nKerley JS, Olsen SL, Freemantle SJ, Spinella MJ.
    \nBiochem Biophys Res Commun<\/span>. 2001 Jul 27;285(4):969-75.
    \nPMID: 11467847 [PubMed – indexed for MEDLINE]\n    Similar articles<\/a><\/li>\n
  47. Retinoic acid activates p53 in human embryonal carcinoma through retinoid receptor-dependent stimulation of p53 transactivation function.<\/a>
    \nCurtin JC, Dragnev KH, Sekula D, Christie AJ, Dmitrovsky E, Spinella MJ.
    \nOncogene<\/span>. 2001 May 3;20(20):2559-69.
    \nPMID: 11420666 [PubMed – indexed for MEDLINE] Free Article
    \n    Similar articles<\/a><\/li>\n
  48. Aerosolized delivery and lung cancer prevention: pre-clinical models show promise.<\/a>
    \nSpinella MJ, Dmitrovsky E.
    \nClin Cancer Res<\/span>. 2000 Aug;6(8):2963-4. No abstract available.
    \nPMID: 10955769 [PubMed – indexed for MEDLINE] Free Article
    \n    Similar articles<\/a><\/li>\n
  49. Aberrant retinoid signaling and breast cancer: the view from outside the nucleus.<\/a>
    \nSpinella MJ, Dmitrovsky E.
    \nJ Natl Cancer Inst<\/span>. 2000 Mar 15;92(6):438-40. No abstract available.
    \nPMID: 10716952 [PubMed – indexed for MEDLINE]\n    Similar articles<\/a><\/li>\n
  50. 4HPR triggers apoptosis but not differentiation in retinoid sensitive and resistant human embryonal carcinoma cells through an RARgamma independent pathway.<\/a>
    \nKitareewan S, Spinella MJ, Allopenna J, Reczek PR, Dmitrovsky E.
    \nOncogene<\/span>. 1999 Oct 14;18(42):5747-55.
    \nPMID: 10523855 [PubMed – indexed for MEDLINE] Free Article
    \n    Similar articles<\/a><\/li>\n
  51. Retinoic acid promotes ubiquitination and proteolysis of cyclin D1 during induced tumor cell differentiation.<\/a>
    \nSpinella MJ, Freemantle SJ, Sekula D, Chang JH, Christie AJ, Dmitrovsky E.
    \nJ Biol Chem<\/span>. 1999 Jul 30;274(31):22013-8.
    \nPMID: 10419526 [PubMed – indexed for MEDLINE] Free Article
    \n    Similar articles<\/a><\/li>\n
  52. A novel synthetic oleanane triterpenoid, 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid, with potent differentiating, antiproliferative, and anti-inflammatory activity.<\/a>
    \nSuh N, Wang Y, Honda T, Gribble GW, Dmitrovsky E, Hickey WF, Maue RA, Place AE, Porter DM, Spinella MJ, Williams CR, Wu G, Dannenberg AJ, Flanders KC, Letterio JJ, Mangelsdorf DJ, Nathan CF, Nguyen L, Porter WW, Ren RF, Roberts AB, Roche NS, Subbaramaiah K, Sporn MB.
    \nCancer Res<\/span>. 1999 Jan 15;59(2):336-41.
    \nPMID: 9927043 [PubMed – indexed for MEDLINE] Free Article
    \n    Similar articles<\/a><\/li>\n
  53. FGF4 dissociates anti-tumorigenic from differentiation signals of retinoic acid in human embryonal carcinomas.<\/a>
    \nMaerz WJ, Baselga J, Reuter VE, Mellado B, Myers ML, Bosl GJ, Spinella MJ, Dmitrovsky E.
    \nOncogene<\/span>. 1998 Aug 13;17(6):761-7.
    \nPMID: 9715278 [PubMed – indexed for MEDLINE] Free Article
    \n    Similar articles<\/a><\/li>\n
  54. Specific retinoid receptors cooperate to signal growth suppression and maturation of human embryonal carcinoma cells.<\/a>
    \nSpinella MJ, Kitareewan S, Mellado B, Sekula D, Khoo KS, Dmitrovsky E.
    \nOncogene<\/span>. 1998 Jul 2;16(26):3471-80.
    \nPMID: 9692555 [PubMed – indexed for MEDLINE] Free Article
    \n    Similar articles<\/a><\/li>\n
  55. Organization of the murine reduced folate carrier gene and identification of variant splice forms.<\/a>
    \nBrigle KE, Spinella MJ, Sierra EE, Goldman ID.
    \nBiochim Biophys Acta<\/span>. 1997 Aug 7;1353(2):191-8.
    \nPMID: 9294013 [PubMed – indexed for MEDLINE]\n    Similar articles<\/a><\/li>\n
  56. Cloning of the human orphan receptor germ cell nuclear factor\/retinoid receptor-related testis-associated receptor and its differential regulation during embryonal carcinoma cell differentiation.<\/a>
    \nLei W, Hirose T, Zhang LX, Adachi H, Spinella MJ, Dmitrovsky E, Jetten AM.
    \nJ Mol Endocrinol<\/span>. 1997 Apr;18(2):167-76.
    \nPMID: 9134503 [PubMed – indexed for MEDLINE]\n    Similar articles<\/a><\/li>\n
  57. pH dependence of methotrexate transport by the reduced folate carrier and the folate receptor in L1210 leukemia cells. Further evidence for a third route mediated at low pH.<\/a>
    \nSierra EE, Brigle KE, Spinella MJ, Goldman ID.
    \nBiochem Pharmacol<\/span>. 1997 Jan 24;53(2):223-31.
    \nPMID: 9037255 [PubMed – indexed for MEDLINE]\n    Similar articles<\/a><\/li>\n
  58. Comparison of methotrexate polyglutamylation in L1210 leukemia cells when influx is mediated by the reduced folate carrier or the folate receptor. Lack of evidence for influx route-specific effects.<\/a>
    \nSpinella MJ, Brigle KE, Freemantle SJ, Sierra EE, Goldman ID.
    \nBiochem Pharmacol<\/span>. 1996 Sep 13;52(5):703-12.
    \nPMID: 8765468 [PubMed – indexed for MEDLINE]\n    Similar articles<\/a><\/li>\n
  59. Molecular cloning of murine folylpoly-gamma-glutamate synthetase.<\/a>
    \nSpinella MJ, Brigle KE, GoldmanD.
    \nBiochim Biophys Acta<\/span>. 1996 Feb 7;1305(1-2):11-4.
    \nPMID: 8605241 [PubMed – indexed for MEDLINE]\n    Similar articles<\/a><\/li>\n
  60. Comparison of transport properties of the reduced folate carrier and folate receptor in murine L1210 leukemia cells.<\/a>
    \nSierra EE, Brigle KE, Spinella MJ, Goldman ID.
    \nBiochem Pharmacol<\/span>. 1995 Oct 12;50(8):1287-94.
    \nPMID: 7488246 [PubMed – indexed for MEDLINE]\n    Similar articles<\/a><\/li>\n
  61. Characterization of a mutation in the reduced folate carrier in a transport defective L1210 murine leukemia cell line.<\/a>
    \nBrigle KE, Spinella MJ, Sierra EE, Goldman ID.
    \nJ Biol Chem<\/span>. 1995 Sep 29;270(39):22974-9.
    \nPMID: 7559435 [PubMed – indexed for MEDLINE] Free Article
    \n    Similar articles<\/a><\/li>\n
  62. Conjugates of folate and anti-T-cell-receptor antibodies specifically target folate-receptor-positive tumor cells for lysis.<\/a>
    \nKranz DM, Patrick TA, Brigle KE, Spinella MJ, Roy EJ.
    \nProc Natl Acad Sci U S A<\/span>. 1995 Sep 26;92(20):9057-61.
    \nPMID: 7568072 [PubMed – indexed for MEDLINE] Free PMC Article
    \n    Similar articles<\/a><\/li>\n
  63. Distinguishing between folate receptor-alpha-mediated transport and reduced folate carrier-mediated transport in L1210 leukemia cells.<\/a>
    \nSpinella MJ, Brigle KE, Sierra EE, Goldman ID.
    \nJ Biol Chem<\/span>. 1995 Apr 7;270(14):7842-9.
    \nPMID: 7713875 [PubMed – indexed for MEDLINE] Free Article
    \n    Similar articles<\/a><\/li>\n
  64. Increased expression and characterization of two distinct folate binding proteins in murine erythroleukemia cells.<\/a>
    \nBrigle KE, Spinella MJ, Westin EH, Goldman ID.
    \nBiochem Pharmacol<\/span>. 1994 Jan 20;47(2):337-45.
    \nPMID: 8304978 [PubMed – indexed for MEDLINE]\n    Similar articles<\/a><\/li>\n
  65. Endothelin-receptor interactions. Role of a putative sulfhydryl on the endothelin receptor.<\/a>
    \nSpinella MJ, Kottke R, Magazine HI, Healy MS, Catena JA, Wilken P, Andersen TT.
    \nFEBS Lett<\/span>. 1993 Aug 9;328(1-2):82-8.
    \nPMID: 8344436 [PubMed – indexed for MEDLINE] Free Article
    \n    Similar articles<\/a><\/li>\n
  66. A specific endothelin-1 antagonist blocks inhaled endothelin-1-induced bronchoconstriction in sheep.<\/a>
    \nAbraham WM, Ahmed A, Cortes A, Spinella MJ, Malik AB, Andersen TT.
    \nJ Appl Physiol (1985)<\/span>. 1993 May;74(5):2537-42.
    \nPMID: 8335588 [PubMed – indexed for MEDLINE]\n    Similar articles<\/a><\/li>\n
  67. Design and synthesis of a specific endothelin 1 antagonist: effects on pulmonary vasoconstriction.<\/a>
    \nSpinella MJ, Malik AB, Everitt J, Andersen TT.
    \nProc Natl Acad Sci U S A<\/span>. 1991 Aug 15;88(16):7443-6.
    \nPMID: 1871142 [PubMed – indexed for MEDLINE] Free PMC Article
    \n    Similar articles<\/a><\/li>\n
  68. Facial nerve paralysis with benign parotid masses.<\/a>
    \nDeLozier HL, Spinella MJ, Johnson GD.
    \nAnn Otol Rhinol Laryngol<\/span>. 1989 Aug;98(8 Pt 1):644-7.
    \nPMID: 2764449 [PubMed – indexed for MEDLINE]\n    Similar articles<\/a><\/li>\n
  69. A proposed structural model of endothelin.<\/a>
    \nSpinella MJ, Krystek SR Jr, Peapus DH, Wallace BA, Bruner C, Andersen TT.
    \nPept Res<\/span>. 1989 Jul-Aug;2(4):286-91.
    \nPMID: 2520767 [PubMed – indexed for MEDLINE]\n    Similar articles<\/a><\/li>\n<\/ol>\n<\/div>
    <\/div><\/div><\/div><\/div><\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":3,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"open","template":"","meta":{"footnotes":""},"class_list":["post-1725","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/vetmed.illinois.edu\/spinella-freemantle-lab\/wp-json\/wp\/v2\/pages\/1725","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vetmed.illinois.edu\/spinella-freemantle-lab\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/vetmed.illinois.edu\/spinella-freemantle-lab\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/vetmed.illinois.edu\/spinella-freemantle-lab\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/vetmed.illinois.edu\/spinella-freemantle-lab\/wp-json\/wp\/v2\/comments?post=1725"}],"version-history":[{"count":19,"href":"https:\/\/vetmed.illinois.edu\/spinella-freemantle-lab\/wp-json\/wp\/v2\/pages\/1725\/revisions"}],"predecessor-version":[{"id":1921,"href":"https:\/\/vetmed.illinois.edu\/spinella-freemantle-lab\/wp-json\/wp\/v2\/pages\/1725\/revisions\/1921"}],"wp:attachment":[{"href":"https:\/\/vetmed.illinois.edu\/spinella-freemantle-lab\/wp-json\/wp\/v2\/media?parent=1725"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}